Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 24, 2023 - Issue 3-4
Submit an article Journal homepage
7,831
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trials

Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS

Shiran Salomon-Zimri1 NeuroSense Therapeutics, Ltd, Herzliya, IsraelCorrespondence[email protected]
View further author information
,
Avital Pushett1 NeuroSense Therapeutics, Ltd, Herzliya, IsraelView further author information
,
Niva Russek-Blum1 NeuroSense Therapeutics, Ltd, Herzliya, Israel;2 The Dead Sea Arava Science Center, Auspices of Ben Gurion University, Central Arava, IsraelView further author information
,
Ruben P. A. Van Eijk3 Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands;4 Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Nurit Birman5 Neuromuscular Diseases Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelView further author information
,
Beatrice Abramovich5 Neuromuscular Diseases Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelView further author information
,
Erez Eitan6 NeuroDex Incorporated, Natick, MA, USAView further author information
,
Katya Elgrart6 NeuroDex Incorporated, Natick, MA, USAView further author information
,
Danielle Beaulieu7 Origent Data Sciences, Inc, Vienna, VA, USAView further author information
,
David L. Ennist7 Origent Data Sciences, Inc, Vienna, VA, USAView further author information
,
James D. Berry8 Department of Neurology Massachusetts General Hospital, Harvard Medical School, Sean M. Healey and AMG Center for ALS at Mass General and Neurological Clinical Research Institute, Boston, MA, USAView further author information
,
Sabrina Paganoni8 Department of Neurology Massachusetts General Hospital, Harvard Medical School, Sean M. Healey and AMG Center for ALS at Mass General and Neurological Clinical Research Institute, Boston, MA, USAView further author information
,
Jeremy M. Shefner9 Barrow Neurological Institute, Phoenix, AZ, USA, andView further author information
&
Vivian E. Drory5 Neuromuscular Diseases Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;10 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, IsraelView further author information
 show all
Pages 263-271 | Received 26 May 2022, Accepted 29 Aug 2022, Published online: 15 Sep 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.